Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Comparison of twice-daily and four-times daily administration of beclomethasone dipropionate in patients with severe chronic bronchial asthma

Comparison of twice-daily and four-times daily administration of beclomethasone dipropionate in... 228 30 30 3 3 H. Tukiainen J. Vaara E. Terho P. Karttunen M. Silvasti Department of Pulmonary Diseases Kuopio University Central Hospital Kuopio Finland Kuopio Regional Institute of Occupational Health Kuopio Finland Medical Department Orion Corporation Ltd. Remeda Pharmaceutical Kuopio Finland Summary Twice-daily and four-times daily treatment with beclomethasone dipropionate aerosol were compared in a double dummy crossover study in patients with severe chronic bronchial asthma. The trial consisted of two two-month treatment periods preceded by a two-week baseline period. No significant difference was found in the morning or evening PEF, in symptom scores for wheeze, cough, sputum, sleep disturbance, limitation of daily activity, rhinitis, daily usage of bronchodilator aerosol or requirement for additional oral corticosteroids. The study has confirmed that in management of severe bronchial asthma, a twice-daily regimen of beclomethasone dipropionate aerosol is as effective as four-times daily treatment, if the total daily dose of beclomethasone dipropionate is kept unchanged. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Clinical Pharmacology Springer Journals

Comparison of twice-daily and four-times daily administration of beclomethasone dipropionate in patients with severe chronic bronchial asthma

Loading next page...
 
/lp/springer-journals/comparison-of-twice-daily-and-four-times-daily-administration-of-9Hawqf0pz3

References (8)

Publisher
Springer Journals
Copyright
Copyright © 1986 by Springer-Verlag
Subject
Biomedicine; Pharmacology/Toxicology
ISSN
0031-6970
eISSN
1432-1041
DOI
10.1007/BF00541536
Publisher site
See Article on Publisher Site

Abstract

228 30 30 3 3 H. Tukiainen J. Vaara E. Terho P. Karttunen M. Silvasti Department of Pulmonary Diseases Kuopio University Central Hospital Kuopio Finland Kuopio Regional Institute of Occupational Health Kuopio Finland Medical Department Orion Corporation Ltd. Remeda Pharmaceutical Kuopio Finland Summary Twice-daily and four-times daily treatment with beclomethasone dipropionate aerosol were compared in a double dummy crossover study in patients with severe chronic bronchial asthma. The trial consisted of two two-month treatment periods preceded by a two-week baseline period. No significant difference was found in the morning or evening PEF, in symptom scores for wheeze, cough, sputum, sleep disturbance, limitation of daily activity, rhinitis, daily usage of bronchodilator aerosol or requirement for additional oral corticosteroids. The study has confirmed that in management of severe bronchial asthma, a twice-daily regimen of beclomethasone dipropionate aerosol is as effective as four-times daily treatment, if the total daily dose of beclomethasone dipropionate is kept unchanged.

Journal

European Journal of Clinical PharmacologySpringer Journals

Published: May 1, 1986

There are no references for this article.